Skip to main content

Table 1 The characteristics after 7-week treatment in rats with chronic heart failure

From: Chronic vagal nerve stimulation exerts additional beneficial effects on the beta-blocker-treated failing heart

 

SS group (n = 11)

SSM group (n = 11)

VSM group (n = 12)

BW (g)

432 ± 14

427 ± 16

425 ± 8

Infarct size (%)

44 ± 2

45 ± 2

44 ± 1

HW (g/kg)

3.26 ± 0.19

2.96 ± 0.06

2.67 ± 0.08*,#

Lung W (g/kg)

7.51 ± 0.45

9.49 ± 0.83

7.46 ± 0.85

Liver W (g/kg)

29.38 ± 0.90

33.49 ± 1.33

31.14 ± 0.80

Death number

7 (7/18, 39%)

4 (4/15, 27%)

1 (1/13, 8%)*

  1. Values are mean ± SEM. For data of BW, HW, lung W, liver W and infarct size, differences among three groups were tested by ANOVA, with Scheffé’s multiple comparison test. The effect of treatment on 50-day survival was analyzed by a log-rank test
  2. BW body weight, HW biventricular weight normalized by body weight, lung W lung weight normalized by body weight, liver W liver weight normalized by body weight
  3. *P < 0.05 vs. SS group
  4. #P < 0.05 vs. SSM group